Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Login

    Lexaria Bioscience Corp.

    NASDAQ: LEXX · Real-Time Price · USD
    1.01
    0.00 (0.00%)
    At close: Jun 17, 2025, 3:23 PM

    Lexaria Bioscience Statistics

    Share Statistics

    Lexaria Bioscience has 19.48M shares outstanding. The number of shares has increased by 22.55% in one year.

    Shares Outstanding

    n/a
    		 19.48M

    Shares Change (YoY)

    n/a
    		 22.55%

    Shares Change (QoQ)

    n/a
    		 0.57%

    Owned by Institutions (%)

    n/a
    		 8.65%

    Shares Floating

    n/a
    		 17.95M

    Failed to Deliver (FTD) Shares

    n/a
    		 1,380

    FTD / Avg. Volume

    n/a
    		 1.19%

    Short Selling Information

    The latest short interest is 580.82K, so 3.31% of the outstanding shares have been sold short.

    Short Interest

    n/a
    		 580.82K

    Short % of Shares Out

    n/a
    		 3.31%

    Short % of Float

    n/a
    		 3.72%

    Short Ratio (days to cover)

    n/a
    		 7.07

    Valuation Ratios

    The PE ratio is -8.36 and the forward PE ratio is -1.75. Lexaria Bioscience's PEG ratio is 0.16.

    PE Ratio

    n/a
    		 -8.36

    Forward PE

    n/a
    		 -1.75

    PS Ratio

    n/a
    		 104.29

    Forward PS

    n/a
    		 0.3

    PB Ratio

    n/a
    		 6.03

    P/FCF Ratio

    n/a
    		 -9.76

    PEG Ratio

    n/a
    		 0.16
    Financial Ratio History

    Enterprise Valuation

    Currently the Enterprise Value (EV) is not available for Lexaria Bioscience.

    EV / Sales

    n/a
    		 n/a

    EV / EBITDA

    n/a
    		 n/a

    EV / EBIT

    n/a
    		 n/a

    EV / FCF

    n/a
    		 n/a

    Financial Position

    The company has a current ratio of 7.18, with a Debt / Equity ratio of 0.02.

    Current Ratio

    n/a
    		 7.18

    Quick Ratio

    n/a
    		 7.18

    Debt / Equity

    n/a
    		 0.02

    Debt / EBITDA

    n/a
    		 -0.02

    Debt / FCF

    n/a
    		 -0.03

    Interest Coverage

    n/a
    		 0

    Financial Efficiency

    Return on Equity is n/a and Return on Invested Capital is n/a.

    Return on Equity

    n/a
    		 n/a

    Return on Assets

    n/a
    		 n/a

    Return on Invested Capital

    n/a
    		 n/a

    Revenue Per Employee

    n/a
    		 $66,325.43

    Profits Per Employee

    n/a
    		 $-827,906.43

    Employee Count

    n/a
    		 7

    Asset Turnover

    n/a
    		 0.05

    Inventory Turnover

    n/a
    		 n/a

    Taxes

    Income Tax

    n/a
    		 n/a

    Effective Tax Rate

    n/a
    		 0%

    Stock Price Statistics

    The stock price has increased by -64.85% in the last 52 weeks. The beta is 0.94, so Lexaria Bioscience's price volatility has been higher than the market average.

    Beta

    n/a
    		 0.94

    52-Week Price Change

    n/a
    		 -64.85%

    50-Day Moving Average

    n/a
    		 1.16

    200-Day Moving Average

    n/a
    		 1.99

    Relative Strength Index (RSI)

    n/a
    		 45.22

    Average Volume (20 Days)

    n/a
    		 116,420

    Income Statement

    In the last 12 months, Lexaria Bioscience had revenue of 464.28K and earned -5.8M in profits. Earnings per share was -0.47.

    Revenue

    n/a
    		 464.28K

    Gross Profit

    n/a
    		 459.46K

    Operating Income

    n/a
    		 -5.75M

    Net Income

    n/a
    		 -5.8M

    EBITDA

    n/a
    		 -5.68M

    EBIT

    n/a
    		 -5.75M

    Earnings Per Share (EPS)

    n/a
    		 -0.47
    Full Income Statement

    Balance Sheet

    The company has 6.5M in cash and 137.37K in debt, giving a net cash position of 6.36M.

    Cash & Cash Equivalents

    n/a
    		 6.5M

    Total Debt

    n/a
    		 137.37K

    Net Cash

    n/a
    		 6.36M

    Retained Earnings

    n/a
    		 -51.56M

    Total Assets

    n/a
    		 8.68M

    Working Capital

    n/a
    		 5.9M
    Full Balance Sheet

    Cash Flow

    In the last 12 months, operating cash flow was -4.96M and capital expenditures -43.02K, giving a free cash flow of -4.96M.

    Operating Cash Flow

    n/a
    		 -4.96M

    Capital Expenditures

    n/a
    		 -43.02K

    Free Cash Flow

    n/a
    		 -4.96M

    FCF Per Share

    n/a
    		 -0.4
    Full Cash Flow Statement

    Margins

    Gross margin is 98.96%, with operating and profit margins of -1239.16% and -1248.25%.

    Gross Margin

    n/a
    		 98.96%

    Operating Margin

    n/a
    		 -1239.16%

    Pretax Margin

    n/a
    		 -1251.12%

    Profit Margin

    n/a
    		 -1248.25%

    EBITDA Margin

    n/a
    		 -1222.75%

    EBIT Margin

    n/a
    		 -1239.16%

    FCF Margin

    n/a
    		 -1068.11%

    Dividends & Yields

    LEXX does not appear to pay any dividends at this time.

    Dividend Per Share

    n/a
    		 n/a

    Dividend Yield

    n/a
    		 n/a

    Dividend Growth (YoY)

    n/a
    		 n/a

    Payout Ratio

    n/a
    		 n/a

    Earnings Yield

    n/a
    		 n/a

    FCF Yield

    n/a
    		 n/a
    Dividend Details

    Analyst Forecast

    The average price target for LEXX is $7, which is 579.6% higher than the current price. The consensus rating is "Buy".

    Price Target

    n/a
    		 $7

    Price Target Difference

    n/a
    		 579.6%

    Analyst Consensus

    n/a
    		 Buy

    Analyst Count

    n/a
    		 1
    Stock Forecasts

    Fair Value

    There are several formulas that can be used to estimate the intrinsic value of a stock.

    Lynch Fair Value

    n/a
    		 n/a

    Lynch Upside

    n/a
    		 n/a

    Graham Number

    n/a
    		 n/a

    Graham Upside

    n/a
    		 n/a

    Stock Splits

    The last stock split was on Jan 12, 2021. It was a backward split with a ratio of 1:30.

    Last Split Date

    n/a
    		 Jan 12, 2021

    Split Type

    n/a
    		 backward

    Split Ratio

    n/a
    		 1:30

    Scores

    Altman Z-Score

    n/a
    		 -5.6

    Piotroski F-Score

    n/a
    		 2

    Add to Watchlist